The VERIFI® test from Selecta Labs, represents a major advance in prenatal testing, providing accurate answers about fetal chromosomal health, without the risks associated with invasive procedures.
What is VERIFI®
The VERIFI® prenatal test is a simple—noninvasive blood test that screens for the most common chromosomal abnormalities that can affect an infant’s future health. The VERIFI® test is available for both singleton and twin pregnancies. Test results are usually reported back to your healthcare provider within approximately one week’s time.
Who to Test?
The VERIFI® test offers parents-to-be a new choice to obtain important information about the health of their developing baby, simply, accurately and in the first trimester (at 10 weeks), with little or no risk to their pregnancy.
This screening test is usually offered to pregnant women identified by their doctor to have a chance of fetal aneuploidy. It may be an option for you to consider if you have a confirmed singleton or twin pregnancy of at least 10 weeks’ gestational age, and meet any of the following criteria:
- Patient is considered to be of advanced maternal age at time of delivery (35 years or older for a singleton pregnancy or 32 years or older for a twin pregnancy)
- Patient ultrasound shows concerns or abnormalities with fetal growth and/or development
- Patient has a personal or family history suggestive of trisomies 21, 18, 13, or other sex chromosome aneuploidies
- Patient has an abnormal or “positive” serum screen
What do VERIFI® results indicate?
Results tell the provider whether or not trisomies 21, 18, 13 or sex chromosome abnormalities (if ordered) are highly likely to be present in pregnancy. In
the case of a positive result, the provider will discuss what the results mean to your pregnancy as well as further testing options to consider.
Your test report will include one of three possible results for chromosomes 21, 18, and 13:
- No Aneuploidy Detected—means the expected number of chromosomes was found
- Aneuploidy Detected—means too many or too few copies of one of the chromosomes have been identified. This can indicate a chromosome abnormality. Your provider may advise a diagnostic test for confirmation
| VERIFI® Test from Selecta Labs | Available Targeted Sequencing Tests |
| Definite, informative results | Ambiguous risk scores similar to serum screens |
| Lowest test failure rate (0.1%) | High failure rates (5%-10% or greater) |
| Not constrained by patient factors or paternal sample | May reply on patient factors or require paternal samples to improve accuracy |
| Accepts egg donors | May exclude egg donors |